# Hydrochlorothiazide

NDC: 50228-111
Generic name: Hydrochlorothiazide
Labeler / Manufacturer: ScieGen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20140723

FDA application: ANDA203018

## Active ingredients

- HYDROCHLOROTHIAZIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50228-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50228-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02e96a51-1d56-460c-8c20-3d6f37e0ce46